Cite

    Dungan, K. et al. (n.d.). A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 diabetes and congestive heart failure exacerbation. Diabetes/metabolism research and reviews. 31 (1), pp. 93-101. [Online].